Inicio › Cáncer de pulmón › Illinois › Evanston
Ensayos clínicos de Cáncer de pulmón en Evanston, IL
19 estudios para Cáncer de pulmón buscan participantes en centros de Evanston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
ReclutandoFase 3
- Illinois Cancer Specialists, Niles · A 6 mi de distancia
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
ReclutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
ReclutandoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · A 5 mi de distancia
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutandoFase 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · A 5 mi de distancia
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
- y 1 más
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
ReclutandoFase 3
- North Shore University Health System ( Site 4014), Evanston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
ReclutandoFase 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · A 5 mi de distancia
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
ReclutandoEstudio observacional
- Northshore University Health System, Evanston
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
ReclutandoFase 3
- Illinois Cancer Specialists, Niles · A 6 mi de distancia
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · A 5 mi de distancia
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
ReclutandoFase 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · A 5 mi de distancia
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
ReclutandoFase 3
- Illinois Cancer Specialists, Niles · A 6 mi de distancia
A Registry for People With Lung Cancer
ReclutandoEstudio observacional
- Endeavor Health, Evanston
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutandoFase 3
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
ReclutandoFase 2
- Advocate Aurora Health, Park Ridge · A 8 mi de distancia
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
ReclutandoFase 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · A 5 mi de distancia
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
ReclutandoSe aceptan voluntarios sanos
- Northwestern University, Evanston
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
ReclutandoEstudio observacional
- Advocate Lutheran General Hospital, Park Ridge · A 8 mi de distancia
Más información sobre Cáncer de pulmón en MedlinePlus
Ensayos de Cáncer de pulmón en otras ciudades
- Houston, TX78 estudios
- Boston, MA63 estudios
- New York City, NY60 estudios
- Los Angeles, CA45 estudios
- Chicago, IL43 estudios
- Arlington, VA42 estudios
- Washington, DC41 estudios
- Baltimore, MD41 estudios
- Nashville, TN39 estudios
- St. Louis, MO37 estudios
- Columbus, OH36 estudios
- Philadelphia, PA36 estudios
Otros estudios en Evanston
- Cáncer de pulmón de células no pequeñas21 estudios
- Cáncer de seno13 estudios
- Leucemia mielógena aguda11 estudios
- Cáncer de próstata10 estudios
- Obesidad10 estudios
- Cáncer del colon y del recto10 estudios
- Cáncer (todos los tipos)9 estudios
- Colitis ulcerativa9 estudios
- Sobrepeso9 estudios
- Enfermedad de Crohn9 estudios
- Fibrilación auricular8 estudios
- Melanoma8 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.